Novo Nordisk extends U.S. supply curbs on weight-loss drug Wegovy Summary Novo Nordisk, the Danish pharmaceutical company, has announced that it will continue to restrict the supply of starter doses of its weight-loss drug, Wegovy, in the United States until at least 2024. This decision comes as the company struggles to meet the skyrocketing demand […]
Novo Nordisk Raises Guidance as Sales of Weight-Loss Drug, Wegovy, Soar Novo Nordisk, a Danish pharmaceutical company, has raised its outlook as revenue from its weight-loss treatment, Wegovy, skyrocketed. The company reported that Wegovy revenue soared 537% to 7.5 billion Danish kroner ($1.1 billion) in the second quarter. Total sales were up 32% to 54.3 […]